A detailed history of Parallel Advisors, LLC transactions in Accuray Inc stock. As of the latest transaction made, Parallel Advisors, LLC holds 40,000 shares of ARAY stock, worth $79,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,000
Previous 40,000 -0.0%
Holding current value
$79,200
Previous $72,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

SELL
$2.44 - $3.08 $510,018 - $643,793
-209,024 Reduced 83.94%
40,000 $113,000
Q2 2023

May 20, 2024

BUY
$2.7 - $3.97 $95,669 - $140,669
35,433 Added 16.59%
249,024 $963,000
Q2 2023

Aug 04, 2023

BUY
$2.7 - $3.97 $95,669 - $140,669
35,433 Added 16.59%
249,024 $963,000
Q1 2023

May 20, 2024

BUY
$2.06 - $3.18 $357,597 - $552,019
173,591 Added 433.98%
213,591 $634,000
Q4 2022

Feb 03, 2023

BUY
$1.88 - $2.4 $35,176 - $44,906
18,711 Added 9.6%
213,591 $446,000
Q4 2021

Jan 20, 2022

BUY
$3.72 - $5.88 $75,065 - $118,652
20,179 Added 11.55%
194,880 $930,000
Q3 2021

Nov 02, 2021

SELL
$3.5 - $4.56 $819 - $1,067
-234 Reduced 0.13%
174,701 $690,000
Q2 2021

Aug 06, 2021

BUY
$4.24 - $5.51 $992 - $1,289
234 Added 0.13%
174,935 $791,000
Q4 2020

Feb 02, 2021

BUY
$2.53 - $4.71 $73,926 - $137,626
29,220 Added 20.09%
174,701 $729,000
Q4 2019

Jan 30, 2020

BUY
$2.56 - $3.08 $56,194 - $67,609
21,951 Added 17.77%
145,481 $410,000
Q3 2019

Nov 01, 2019

BUY
$2.58 - $4.14 $318,707 - $511,414
123,530 New
123,530 $342,000
Q2 2019

Aug 05, 2019

SELL
$3.54 - $4.64 $1,157 - $1,517
-327 Closed
0 $0
Q3 2018

Nov 01, 2018

SELL
$3.48 - $4.6 $490 - $648
-141 Reduced 30.13%
327 $1,000
Q3 2017

Nov 15, 2017

BUY
$3.9 - $4.6 $1,825 - $2,152
468
468 $2,000

Others Institutions Holding ARAY

About ACCURAY INC


  • Ticker ARAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 93,579,696
  • Market Cap $185M
  • Description
  • Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation the...
More about ARAY
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.